This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Is NBIS Building a Full-Stack AI Monetization Engine With NVIDIA Rubin?
by Shreya Majumder
Nebius will deploy NVIDIA's Rubin platform in 2H26, becoming one of the first AI cloud providers to offer Vera Rubin NVL72 in the U.S. and Europe.
Is CoreWeave Building a Durable AI Moat With NVIDIA Rubin?
by Shreya Majumder
CRWV plans to deploy NVIDIA Rubin in 2026, expanding its AI cloud for agentic AI, reasoning models and large-scale inference workloads.
NBIS vs. MSFT: Which AI Infrastructure Stock Has More Upside?
by Shivangi Deora
Nebius offers pure-play AI infrastructure growth, while Microsoft leverages massive scale and embedded AI to dominate enterprise demand.
Can CoreWeave Maintain More Than 60% EBITDA Margins Amid Rising CapEx?
by Zacks Equity Research
CRWV posts Q3 2025 adjusted EBITDA of $838M with margins above 60%, citing AI-optimized infrastructure, contracted demand and a resilient outlook.
CoreWeave vs. Nebius: Which AI Infrastructure Stock is the Better Buy?
by Shreya Majumder
CRWV outpaces NBIS in the AI cloud race on scale and backlog, but leverage, supply delays and lowered guidance raise questions about its growth path.
Do Nebius Mega Deals Increase Customer Concentration Risk?
by Zacks Equity Research
NBIS lands mega AI cloud deals with Microsoft and Meta, selling out GPU capacity and boosting long-term revenue visibility as capex and concentration risks rise.
CRWV Stock Crashes 49% in 3 Months: Buy the Dip or Hold Back for Now?
by Shreya Majumder
CoreWeave has plunged nearly 50% from its highs as supply-chain delays, heavy CapEx and leverage hit shares despite a massive $55.6B backlog.
Can NBIS AI Cloud 3.1's Blackwell Ultra Launch Trigger Growth Momentum?
by Shreya Majumder
Nebius rolls out AI Cloud 3.1 with NVIDIA Blackwell Ultra, global GPU visibility and stronger security for enterprises scaling AI.
Nebius Stock Up 74% in Six Months: Should Investors Hold or Offload?
by Shivangi Deora
NBIS stock surges in six months, but stretched valuation, rising costs and execution risks are raising doubts about its near-term outlook.
Will Mission Control's Upgrades Buoy CRWV's Position in Enterprise AI?
by Shreya Majumder
CoreWeave's expanded Mission Control boosts AI workload visibility and reliability even as supply constraints weigh on its outlook.